SUNVAX MRNA THERAPEUTICS
Live / Applied — Second extension granted (statement of use) (as of 15 Jul 2025)
What this means for you
Not registered yet, but its 28 Jul 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98107092
- Mark type
- Design + words
- Filed
- 28 Jul 2023
- Published for opposition
- 21 May 2024
- Attorney of record
- Daniel L. Shores
Goods and services
- Class 001 — Chemicals: Lipids used in the manufacture of cosmetics, beverages, food products and food supplements for industry and scientific use; Nucleotides for scientific and industrial research use in the nature of mRNA and lipid nanoparticle-mRNA; nanoparticles for industrial purposes and scientific use, namely, lipid nanoparticles for mRNA delivery
Owner
- SUNVAX MRNA THERAPEUTICS INC., Beverly, MA, US
- SUNVAX MRNA THERAPEUTICS INC., Beverly, MA, US
Prosecution history
- 08 Jan 2026 — TEAS STATEMENT OF USE RECEIVED
- 16 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Jul 2025 — SOU EXTENSION 2 GRANTED
- 15 Jul 2025 — SOU EXTENSION 2 FILED
- 15 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Jan 2025 — SOU EXTENSION 1 GRANTED
- 08 Jan 2025 — SOU EXTENSION 1 FILED
- 08 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 16 Jul 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 21 May 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 May 2024 — PUBLISHED FOR OPPOSITION
- 01 May 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 Apr 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 15 Apr 2024 — EXAMINER'S AMENDMENT ENTERED